πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,022 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8058280

Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8057990

Screening method

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8048909

Proton pump inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8044049

Fused heterocyclic derivative and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8039500

Fused heterocyclic compounds

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8034812

Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent th

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8030337

Tricyclic compound and pharmaceutical use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8030333

Benzimidazole compound crystal

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8030317

MAPK/ERK kinase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8026234

Polo-like kinase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8022057

MAPK/ERK kinase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8013008

Cyclic amine compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8008525

Receptor function regulating agent

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8003785

Halo-substituted pyrimidodiazepines

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7998684

Screening method for an agent for treatment of neurodegenerative disease

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7998968

Substituted pyrimidines and [1,2, 4] triazoles and the use thereof for treating prophylaxi

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7994332

Process for producing crystal

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7994205

Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7994183

Solid preparation comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-d

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7989445

Thienopyrimidone compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7985863

Iminopyridine derivatives and uses thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7985862

Iminopyridine derivatives and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7982044

Iminopyridine derivatives and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7981598

Preventive/remedy for respiratory diseases

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted